Thrombotic Microangiopathy after Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis-Reference-Cited by-同舟云学术

Thrombotic Microangiopathy after Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis

Published:2020-12 Issue:12 Volume:26 Page:2306-2310
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Imus Philip H.,Tsai Hua-Ling,DeZern Amy E.,Jerde Kevin,Swinnen Lode J.,Bolaños-Meade Javier,Luznik Leo,Fuchs Ephraim J.,Wagner-Johnston Nina,Huff Carol Ann,Gladstone Douglas E.,Ambinder Richard F.,Gocke Christian B.,Ali Syed Abbas,Borrello Ivan M.,Varadhan Ravi,Brodsky Robert,Jones Richard J.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference45 articles.

1. Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation;Powles;Lancet,1980

2. Thrombotic microangiopathy following bone marrow transplantation;Pettitt;Bone Marrow Transplant,1994

3. Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A;Sarkodee-Adoo;Transfusion,2003

4. Syndromes of thrombotic microangiopathy;George;N Engl J Med,2014

5. Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation;Kojouri;Curr Opin Oncol,2007

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transplant-associated thrombotic microangiopathy in pediatrics: incidence, risk factors, therapeutic options, and outcome based on data from a single center;Frontiers in Oncology;2024-07-10

2. Post-transplant cyclophosphamide compared to sirolimus/tacrolimus in reduced intensity conditioning transplants for patients with lymphoid malignancies;Bone Marrow Transplantation;2024-06-24

3. Prospective PTCTC trial of myeloablative haplo-BMT with posttransplant cyclophosphamide for pediatric acute leukemias;Blood Advances;2023-09-26

4. Systematic Review of Signs and Symptoms Associated with Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy;Transplantation and Cellular Therapy;2023-04

5. How I prevent GVHD in high-risk patients: posttransplant cyclophosphamide and beyond;Blood;2023-01-05